Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Announces Appointment of New CEO, Board Member
SHRM appoints top depression researcher as new chief executive officer McIntyre established Canada’s first-ever center to provide rapid-onset treatments for individuals with mood disorders Champignon also announces appointment of new board member Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a Canada-based company dedicated applying novel and natural treatment protocols with an emphasis on psychedelic medicine, has appointed one of the world’s top researchers on depression as its new chief executive officer (http://nnw.fm/M6qzI). In his new role, Dr. Roger McIntyre brings impressive experience in the ketamine and psychedelic medicine space, a key focus area for Champignon. “My overarching aim…
